Simbryo Technologies is a biotechnology company that develops solutions for reproductive health and assisted reproductive technologies.
Simbryo has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in July 2023.
Simbryo's investors include TSVC.
Simbryo is headquartered in Houston, United States.
Simbryo Technologies is a biotechnology company that develops solutions for reproductive health and assisted reproductive technologies.
Simbryo is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Simbryo — Funding & Investors." VCBacked, July 12, 2023, https://www.vcbacked.co/company/simbryo. Accessed October 4, 2026.
VCBacked. (2023). Simbryo — Funding & Investors. Retrieved October 4, 2026, from https://www.vcbacked.co/company/simbryo
{{cite web |title=Simbryo — Funding & Investors |url=https://www.vcbacked.co/company/simbryo |website=VCBacked |access-date=October 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated